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Specific miRNAs are involved in the pathogenesis of multiple sclerosis (MS), during
which IL-17-producing CD4+ T helper (Th17) cells accumulate in the central nervous
system (CNS). In this study, we identified levels of miR-384 as significantly increased
in mice with experimental autoimmune encephalomyelitis (EAE), an animal model
of MS. Over-expression of miR-384 in vivo led to severe EAE, characterized by
exacerbated demyelination, and increased inflammatory cell infiltration of the spinal
cord; inhibition of miR-384 reversed these changes. Both the percentage of Th17,
and ratio of Th17/regulatory T (Treg), cells were elevated in miR-384-transfected EAE
mice, which was consistent with the observed upregulation of expression of IL-17 and
the Th17 lineage-specific transcription factor, RORγt. Importantly, transfer of miR-384
overexpressing naïve T cells from wild-type (WT) to Rag1−/− mice, which are deficient
in functional autologous T and B cells, led to aggravated EAE pathogenesis, while
an miR-384 inhibited group was protected from EAE. Moreover, miR-384 promoted
differentiation of naïve T cells into Th17 cells in vitro. Furthermore, target prediction and
dual luciferase reporter assays demonstrated that suppressor of cytokine signaling 3
(SOCS3), a gene encoding protein with an established role in Th17 differentiation, was
a direct target of miR-384. Our results demonstrate an important role for miR-384 in
regulation of the Th17/Treg ratio during the pathogenesis of EAE, indicating that this
molecule may have potential as a biomarker and/or therapeutic target in MS.
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INTRODUCTION
Multiple sclerosis (MS) in humans, and its animal model, experimental autoimmune
encephalomyelitis (EAE), are characterized by demyelination in the central nervous system (CNS),
as a result of inappropriate inflammation and infiltration of CD4+ T cells (Jadidi-Niaragh and
Mirshafiey, 2011; Rostami and Ciric, 2013). An imbalance between IL-17-producing CD4+ T helper
(Th17) cells, which express the lineage-specific transcription factor, RORγt (Ciofani et al., 2012),
and activated regulatory T (Treg) cells expressing Foxp3 (Gerriets et al., 2016) has a significant
role in induction of inflammatory immune responses (Korn et al., 2009; Liu Y. et al., 2015; Zhu
et al., 2016). This Th17/Treg imbalance is associated with various autoimmune and inflammatory
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diseases, including MS (Tzartos et al., 2008; Jamshidian et al.,
2013, 2015; Lochner et al., 2015). An approach to suppress
Th17 cell differentiation and correct Th17/Treg imbalances
could be an effective treatment for chronic inflammatory
diseases, such as MS.
Although many Th17-specific regulators have been
investigated, the mechanisms underlying abnormal
Th17 generation during MS pathogenesis remain elusive.
MicroRNAs (miRNAs) are a class of endogenous non-coding
RNAs, of approximately 23 nucleotides in length, that regulate
gene expression at the post-transcriptional level (Krol et al.,
2010) and are associated with various autoimmune diseases
(Singh et al., 2013; Chen et al., 2016). Multiple miRNAs have
roles in the development of EAE through targeting specific
proteins in relevant Th17 cell pathways. Over-expression of
miR-326, which targets the transcription factor, Ets-1, results
in increased numbers of Th17 cells and severe EAE in vivo (Du
et al., 2009). In mice with EAE, the expression of miR-155 is
elevated in CD4+T cells, and mice lacking miR-155 develop
milder EAE, and have fewer Th17 cells and less severe CNS
inflammation (O’Connell et al., 2010; Murugaiyan et al., 2011).
MiR-21 also enhances Th17 generation and mediates EAE
development by promoting TGF-β signaling and limiting the
inhibitory effects of IL-2 (Murugaiyan et al., 2015). In addition,
miR-20b, miR-23b and miR-301a are closely associated with
EAE pathogenesis through regulation of factors inducing
Th17 generation, such as RORγt, STAT3 (Zhu et al., 2014),
TAB2, TAB3, IKK-α (Zhu et al., 2012) and PIAS3 in the
IL-6/23-STAT3 pathway (Mycko et al., 2012). Hence there
is a clear and close relationship among miRNA expression,
Th17 cell differentiation, and EAE pathogenesis, suggesting
that specific miRNAs could serve as potential biomarkers or
therapeutic targets in EAE and MS (Li et al., 2010; Zhu et al.,
2012; Zhernakova et al., 2013).
In this study, we discovered that the expression of a specific
miRNA, miR-384, is dramatically upregulated in EAE mice,
suggesting a possible role for miR-384 in this disease. Recently,
a role for miR-384 in tumor progression and neurotoxicity was
identified; however, there are no previous reports of its effects
in EAE pathogenesis. We found that over-expression of miR-384
resulted in promotion of Th17 cell differentiation in vitro and
severe EAE in vivo, due to an excess of Th17 cells, leading to
an imbalance in the Th17/Treg ratio. Hence, our results indicate
that miR-384 is involved in the Th17-mediated pathogenesis of
EAE.
MATERIALS AND METHODS
Mice
C57BL/6 wild-type (WT) and Rag1−/− mice were purchased
from SLAC Laboratory Animal Co., Ltd. (Shanghai, China)
and the Model Animal Research Center of Nanjing University
(Nanjing, China), respectively. All experimental mice were
maintained under specific-pathogen-free conditions in the
animal facility of Xuzhou Medical University (Xuzhou, China).
All experiments were performed in accordance with the
guidelines set out by the US NIH regarding the care and use of
animals for experimental procedures as well as in compliance
with the Provisions and General Recommendations of the
Chinese Experimental Animal Administration Legislation. The
study had institutional approval from the Xuzhou Medical
University Experimental Animal Ethics Committee.
Induction of EAE
C57BL/6 WT mice (7–8 weeks old) were immunized
subcutaneously with 200 µg myelin oligodendrocyte
glycoprotein (MOG) peptide 35–55 (GL Biochem, China)
in complete Freund’s adjuvant (Sigma-Aldrich, St. Louis,
MO, USA) containing 4 mg/mL heat-killed Mycobacterium
tuberculosis H37Ra (Difco, USA). Each mouse received 200 ng
pertussis toxin (Sigma-Aldrich, St. Louis, MO, USA) twice,
administered intraperitoneally (i.p.) on the day of immunization
and 48 h later. Mice immunized without MOG were used as
sham controls. Clinical assessment of EAE was performed daily
after disease induction, and disease severity scored according to
the following criteria (Du et al., 2009): (0) no clinical symptoms;
(1) tail paralysis; (2) hind limb weakness or partial paralysis;
(3) complete paralysis of two hind limbs; (4) paralysis of both
forelimbs and hind limbs; and (5) moribund or dead.
Isolation and Induction of Naïve T Cells
Splenocytes (SPs) or peripheral blood (PB) lymphocytes, isolated
from 5- to 6-week-old C57BL/6 mice, were used to generate
single-cell suspensions depleted of red-blood-cells. Naïve or
CD4+ T cells were purified by magnetic cell sorting according
to the manufacturer’s instructions (Miltenyi Biotec, Germany).
For adoptive transfer studies, each recipient Rag1−/− mouse
was injected intravenously in tail veins with 5 × 106 cells on
the day before EAE induction. Successful reconstitution of cells
was verified by determining GFP expression from the lentivirus
vector (LV).
For Th17 differentiation, purified naïve T cells were cultured
for 3 days under Th17-cell polarizing conditions: RPMI-1640
medium containing 10% fetal calf serum, 1 mM glutamine,
0.1 mM beta-mercaptoethanol, 1% nonessential amino acids
(Sigma–Aldrich, St. Louis, MO, USA), 5 ng/mL IL-2 (R&D
Systems, Minneapolis, MN, USA), 20 ng/mL IL-6, 5 ng/mL
transforming growth factor-β, 10 ng/mL IL-23, 2 µg/mL anti-
IL-4, 2 µg/mL anti-interferon-γ (BD Pharmingen, San Jose, CA,
USA) and anti-CD3 and anti-CD28-coated beads (Invitrogen,
Carlsbad, CA, USA).
Lentivirus Preparation and Administration
For lentivirus-mediated over-expression of miR-384
(uguaaacaauuccuaggcaaugu), the genomic sequence
spanning the mouse miR-384 coding region and ∼70 bp
of flanking sequence was cloned into the lentiviral vector,
H1-MCS-CMV-EGFP (GV-209, Genechem, Shanghai).
For lentivirus-mediated inhibition of miR-384, miR-384
complementary (acauugccuaggaauuguuuaca) or negative control
(uucuccgaacgugucacgu) sequences were cloned into the same
vector. Lentiviruses were produced by Shanghai Genechem
Company. Target naïve T cells were infected at a multiplicity of
infection of 3 for 12 h, according to the user’s manual, before
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induction of Th17 polarization. For administration to mice,
approximately 2 × 107 transforming units of recombinant
lentiviruses were delivered by injection into tail veins 7 days
before EAE induction. GFP+ T cells were collected for further
examination.
Flow Cytometric Analyses
PB-, lymph node-, or spinal cord-infiltrating lymphocytes
were prepared by Percoll gradient centrifugation and then
incubated with Cell Stimulation Cocktail (eBioscience, San
Diego, CA, USA) for 5 h. For intracellular staining, single-cell
suspensions were prepared, surface-stained with FITC-labeled
anti-CD4 antibody (Miltenyi Biotec, Germany), and then fixed
and permeabilized using a Fixation/Permeabilization Kit (BD
Biosciences, San Jose, CA, USA). Subsequently, the cells were
washed and stained with Anti-IL-17-PE antibody (Miltenyi
Biotec, Germany). Co-staining with RORγt, Foxp3, suppressor
of cytokine signaling 3 (SOCS3) rabbit lgGs (CST, USA) was
performed for some experiments, and APC-Goat anti-Rabbit
lgG (Miltenyi Biotec, Germany) were used as secondary
antibodies. Analyses were performed using a MACSQuantTM
FlowCytometer (Miltenyi Biotec, Germany), and the results were
analyzed using FlowJo7.6. Protein expression levels are expressed
as mean fluorescence intensity (MFI).
Quantitative RT-PCR
Total RNA, from CD4+ T cells or spinal cords from mice
anesthetized by i.p. overdose of pentobarbital (150 mg/kg), was
extracted using Trizol reagent (Ambion, USA). Quantitative
RT-PCR analyses of miR-384 levels were performed using
SYBRGreen miRNA assays (Genechem, Shanghai, China) with
U6 small nuclear RNA as an internal reference for normalization.
Myelin basic protein (MBP) mRNA was examined using a
SYBR Green real-time PCR kit on a LightCyclerr 480II
System (Roche, Switzerland). Relative expression of miRNA
or mRNA was evaluated using the 2−44ct method and
expression levels were normalized relative to those of U6 or
β-actin, respectively. The primers used were as follows:
MBP, 5′-ACCCTCACAGCGATCCAAGT-3′ and 5′-TACGGC
TCGGAGCTCACC-3′; and β-actin, 5′-GAGACCTTCAACAC
CCCAGCC-3′ and 5′-AATGTCACGCACGATTTCCC-3′.
Histological Analyses
For histological analyses, mice were anesthetized with
pentobarbital, and then perfused through the left ventricle,
first with normal saline to eliminate the blood and then with
buffered 4% paraformaldehyde. Spinal cords were embedded in
paraffin, and 4 µm thick sections that had been deparaffinized
and rehydrated were stained with hematoxylin and eosin (H&E)
or luxol fast blue (LFB) for analysis of inflammation and
demyelination. Demyelination was quantified in LFB stained
sections by calculation of the area of demyelination relative to
the total area analyzed. Spinal cord infiltrates were quantified as
infiltrates per mm2 in H&E stained sections.
For transmission electron microscopy analyses, fixed and
embedded samples were cut into ultra-thin sections (80 nm) and
stained with uranyl acetate and lead citrate. Electronmicrographs
were captured using an FEI Tecnai G2 T12 transmission
electron microscope (USA). The axonal diameter (d) was
defined as the shortest distance across the center of the
axon, omitting the myelin sheath thickness. Fiber diameter
(D) was defined as the axonal diameter plus the total myelin
sheath thickness on both sides. The g-ratio was calculated
as d/D.
For immunofluorescence analyses, prepared spinal cords were
incubated overnight in sodium phosphate buffer containing
30% sucrose, then embedded in Optimal Cutting Temperature
medium (Leica, Germany) for sectioning. Cryosections (15 µm)
were thawed and washed with 0.01% PBS with 5% BSA and
0.3% Triton X-100, and then incubated with MBP monoclonal
antibody (CST, USA) for 1 h at 37◦C. Following an additional
wash step, specimens were incubated with FITC-Goat IgG
(LI-COR, USA) and the cell nuclei counterstained with 4′,6-
diamidino-2-phenylindole (DAPI). Images were acquired using
a fluorescence microscope system (Olympus, Japan) and MFI
values calculated using ImageJ software.
ELISA
Cerebrospinal fluid was collected from LV-transfected mice
according to a previously described protocol (Liu and Duff,
2008). An IL-17 ELISA kit was purchased from Westang
(Shanghai, China), and ELISA performed according to the
manufacturer’s protocol.
Western Blotting
The spinal cord was stripped and then ultrasonically
homogenized in RIPA buffer. Protein concentrations were
measured using a bicinchoninic acid protein assay kit
(Beyotime, Shanghai, China). Protein samples were separated
by electrophoresis in SDS denaturing 10% polyacrylamide gels
(Beyotime, Shanghai, China) and transferred to nitrocellulose
membranes, which were subsequently blocked in 0.01% PBS
containing 5% BSA. Then membranes were incubated with
MBP and β-actin monoclonal antibodies (CST, USA). After
washing, the membranes were incubated with appropriate
IRDye-conjugated secondary antibodies (LI-COR, Lincoln,
NE, USA), scanned using an Odyssey Infrared Imaging System
Scanner (LI-COR, Lincoln, NE, USA), and the results analyzed
using ImageJ software.
Dual Luciferase Reporter Assay
A fragment of the 3′-UTR of SOCS3, containing the WT
predicted miR-384 binding site, or a mutated form of the site,
and flanking sequences containing suitable enzyme cleavage sites,
was synthesized by Sangon company (Shanghai, China) and
cloned downstream of the luciferase reporter gene. The luciferase
reporter vectors, together with plasmids expressing Renilla
luciferase, and miR-384 or control miR sequences, were each
transfected into 293T cells using Lipofectamine 2000 reagent
(Invitrogen, Carlsbad, CA, USA), following the manufacturer’s
instructions. Cells were harvested 24 h after transfection and
assayed for luciferase activity using a Dual-Luciferase Reporter
Assay System (Promega, Madison, WI, USA).
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Statistical Analyses
Two-tailed Student’s t tests, two-way analysis of variance
followed by Bonferroni’s post hoc test for multiple comparisons,
and Mann-Whitney tests (for nonparametric data; EAE score)
were used to evaluate differences between groups. The results
are expressed as means ± standard deviation (SD). Differences
were considered statistically significant when p < 0.05, and
statistically significant data are indicated by asterisks (∗p < 0.05,
∗∗p< 0.01).
RESULTS
miR-384 Regulates EAE Pathogenesis
To identify specific miRs involved in EAE development, we
determined the expression levels of miRs in PB CD4+ T
cells, which have key roles in EAE pathogenesis. The results
demonstrated that the expression of miR-384 was significantly
elevated in EAE relative to control mice (Figure 1A). To study the
function of miR-384, we injected lentiviral particles expressing
the miR-384 sequence (LV-miR-384), an miR-384 inhibitor
(LV-inhibitor), or control miR (LV-ctrl) into mice before EAE
induction. There were no statistically significant differences
in EAE induction in non-infected, empty-vector-infected and
LV-ctrl-infected EAE mice (data not shown), indicating that
the vector and control sequences had no effect on EAE. Over
the 21 days after immunization, clinical assessment of EAE
demonstrated that LV-miR-384 mice had earlier onset (day 10)
and higher mean disease severity scores (maximum score of
4.0 on day 19) than controls, in which mice began to suffer
from EAE on day 11 and the maximum score was 3.0 on day
20. Moreover, deficiency of miR-384 caused by LV-inhibitor
led to mild EAE from day 13, with a maximum score of only
1.5, on day 19 (Figure 1B). In the lymph nodes (LN) and PB
lymphocytes of mice injected with LV-miR-384, the expression
of miR-384 was more than three times that in controls, while
levels in LV-inhibitor mice were one-third of those in controls
(Figure 1C). Moreover, LV-miR-384 mice suffering from EAE
exhibited the greatest weight loss, while LV-inhibitor group
mice lost the least weight (Figure 1D). These results imply
a potential initiating role for miR-384 in the development
of EAE.
miR-384 Enhances Demyelination in the
Spinal Cord during EAE
To further clarify the impact of miR-384 on the pathogenesis of
EAE, we performed histological analyses of spinal cord sections
by LFB staining. The results indicated that LV-miR-384 mice
had the largest areas of demyelination, while the spinal cords
of LV-inhibitor mice were relatively intact (Figures 2A,B).
Observation by transmission electron microscopy revealed very
FIGURE 1 | MiR-384 regulates encephalomyelitis (EAE) pathogenesis. (A) Quantitative RT-PCR analyses of miR-384 expression in peripheral blood (PB) naïve
CD4+ T cells sorted from control (ctrl) and EAE mice on day 21 after immunization (n = 3 mice per group). Relative miRNA expression levels were evaluated by the
2−44ct method and normalized to the expression of U6. The control was set as 1. (B) Mean EAE scores of lentivirus vector (LV)-transfected mice were recorded daily
(n = 5 mice per group). (C) Quantitative RT-PCR analyses of miR-384 levels in CD4+ T cells from lymph nodes (LN) and PB of LV-transfected mice 7 days later
(n = 3 mice per group). (D) Body weights of LV-transfected mice normalized to the initial body weight of each mouse (n = 5 mice per group). Data are presented as
means ± standard deviation (SD). ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001. Data shown are single representative results from three independent experiments.
LV-ctrl, control miR; LV-miR-384, miR-384 sequence; and LV-inhibitor, miR-384-inhibitor.
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FIGURE 2 | MiR-384 enhances demyelination in the spinal cord during EAE. EAE mice were sacrificed on day 21 after immunization for the following analyses.
Sham controls, mice immunized without myelin oligodendrocyte glycoprotein (MOG) peptide. (A) Representative luxol fast blue (LFB) staining of spinal cords. Boxed
areas in left images are enlarged in the images on the right. Scale bars, 50 µm. (B) Quantification of demyelination in (A). (C) Transmission electron micrographs of
spinal cords. Arrows show myelin sheath damage. Scale bars, 2 µm. (D) Analysis of g-ratios in (C). (E) Quantitative PCR analyses of Myelin basic protein (MBP)
mRNA expression in spinal cords (n = 3 mice per group). Relative expression of mRNA was evaluated by the 2−44ct method and normalized to the expression of
β-actin. The control was set as 1. (F,G) Western blotting analyses of MBP in spinal cords (n = 3 mice per group). (H) MBP immunofluorescence staining of spinal
cords. Boxed areas in left images are enlarged in right images. Scale bars, 50 µm. (I) Statistical analyses of mean fluorescence intensity (MFI) of MBP in H (n = 5 per
group). Data are presented as means ± SD. ∗p < 0.05 and ∗∗p < 0.01. Data shown are single representative results from three independent experiments.
loose and disintegrated myelin sheaths in the spinal cords of
LV-inhibitor and LV-ctrl EAE mice (Figures 2C,D). Next, we
examined the expression of MBP, which is indispensable for the
process of myelination, and found that it was downregulated in
LV-miR-384 mice, and upregulated in the LV-inhibitor group
(Figures 2E–G). Similarly, LV-miR-384 mice had severe myelin
sheath damage in the spinal cord, with the largest area of MBP
loss (Figures 2H,I). Taken together, these findings indicate that
miR-384 exacerbates demyelination in the spinal cord during
EAE pathogenesis.
miR-384 Disturbs the Th17/Treg Ratio
during EAE
EAE is an autoimmune disease model characterized by severe
CNS inflammation. In our study, LV-miR-384 mice developed
more extensive inflammatory cell infiltration in the spinal
cord (Figures 3A,B), consistent with the observed increases in
demyelination and MBP loss (Figure 2). In flow cytometric
analyses, we found that the percentage of IL-17+ Th17 cells
among PB, lymph node and spinal cord infiltrating (SCI)
lymphocytes increasedmore in LV-miR-384mice than in LV-ctrl
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FIGURE 3 | MiR-384 disrupts the Th17/Treg ratio during EAE. (A) Representative hematoxylin and eosin (H&E) staining of spinal cord sections from
LV-transfected and sham control mice. Boxed areas in left images are enlarged in right images. Arrows show lymphocyte infiltration. Scale bars, 50 µm.
(B) Quantification of spinal cord infiltrates in (A). (C) Representative flow cytometric analyses of IL-17+ and Foxp3+ cells among CD4+ gated cells from stimulated
PB, LN and spinal cord infiltrating (SCI) lymphocytes. (D,E) Statistical analyses of the percentage of IL-17+ cells and the ratio between IL-17+ Th17 and Foxp3+ Treg
cells in (B; n = 3 per group). (F) MFI analyses of flow cytometry for RORγt (n = 3 per group). (G) The concentration of IL-17 in serum, cerebrospinal fluid and spinal
cord homogenate was measured by ELISA (n = 5 per group). Data are presented as means ± SD. ∗p < 0.05 and ∗∗p < 0.01. Data shown are single representative
results from three independent experiments.
mice (Figures 3C,D), while the percentage of Foxp3+ Treg
cells showed no obvious differences among the three groups
(Figure 3C). Thus, the relative ratio of Th17 to Treg cells
was largest in LV-miR-384 mice (Figure 3E). Moreover, the
increased number of Th17 cells in LV-miR-384 mice was
confirmed by the observation that the expression of RORγt was
upregulated (Figure 3F), along with IL-17 levels (Figure 3G).
Therefore, miR-384 appears to impact Th17/Treg ratios in EAE
by increasing the number of Th17 cells.
miR-384 Promotes the Generation of
Th17 Cells
To determine the role of miR-384 in Th17 differentiation, naïve
T cells were transfected with LV-miR-384, LV-inhibitor, or
LV-ctrl and then cultured under Th17-polarizing conditions.
Over-expression of miR-384 resulted in a higher percentage
of IL-17+ cells (Figure 4A). Accordingly, the expression
of RORγt (Figure 4B) and secretion of IL-17 (Figure 4C)
were also significantly upregulated by miR-384. Importantly,
transfer of the transfected naïve T cells into age-matched
Rag1−/− mice, which are deficient in functional T and B cells
and hence protected from EAE, restored the susceptibility
of these mice to EAE development; furthermore, mice that
received LV-miR-384-transfected cells suffered from the
most severe EAE, characterized by the earliest onset (on
day 11), highest disease severity score (approximately 3.5;
Figure 4D), and the greatest number of IL-17+ Th17 cells
in spinal cord infiltrates (Figure 4E). Collectively, these
data demonstrate that miR-384 promotes the generation of
Th17 cells.
miR-384 Directly Targets SOCS3
The identification of gene targets for individual miRs is
key to understanding the molecular mechanisms underlying
miR-mediated regulation. Among candidates predicted by
TargetScan, we identified SOCS3, a gene encoding a protein
with an established role in Th17 differentiation, whose 3′-
UTR mRNA sequence closely matched the miR-384 target site
(Figure 5A). We then conducted luciferase reporter assays,
which demonstrated that luciferase activity was reduced by
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FIGURE 4 | MiR-384 promotes the generation of Th17 cells. For the following analyses, naïve T cells were transfected for 12 h and GFP+ cells collected for
tests. (A) Flow cytometric analyses of stimulated IL-17+ cells among the CD4+ gated cells after 3 days of induction under Th17-polarizing conditions. MFI analyses
of (B) flow cytometry for RORγt and (C) ELISA of IL-17 in culture supernatants were also performed (n = 3 per group). (D) Mean EAE scores of Rag1−/− mice
transfected with naïve T cells (n = 5 mice per group). (E) Relative ratio of Th17 cells in SCI lymphocytes from the mice in (D) on day 21 after immunization,
determined by flow cytometric analyses (n = 3 per group). Data are presented as means ± SD. ∗p < 0.05 and ∗∗p < 0.01. Data shown are single representative
results from three independent experiments.
FIGURE 5 | SOCS3 is a direct target of miR-384. (A) Illustration of the
sequence match between miR-384 and SOCS3 mRNA determined using
TargetScan. (B) Luciferase activity of reporter vectors containing wild-type
(WT) or mutated (MUT) SOCS3 3′-UTR co-transfected with miR-384 or control
miR (ctrl; n = 3 per group). (C) MFI analyses of flow cytometry for SOCS3 in
GFP+ naïve T cells 3 days post-transfection (n = 3 per group). Data are
presented as means ± SD. ∗p < 0.05 and ∗∗p < 0.01. Data shown are single
representative results from three independent experiments.
50% in cells co-transfected with the SOCS3 WT luciferase
reporter andmiR-384, compared withmiR-ctrl (Figure 5B, WT).
However, site-directed mutagenesis of the miR-384 recognition
site in the SOCS3 3′-UTR abolished the inhibitory effects of
miR-384 (Figure 5B, MUT). Consistently, the expression of
SOCS3 in naïve T cells over-expressing miR-384 was clearly
lower than that in controls, while downregulation of miR-384
led to increased SOCS3 expression levels (Figure 5C). Taken
together, these results show that miR-384 can regulate SOCS3
expression through a partially complementary binding site in the
3′-UTR.
DISCUSSION
An appropriate balance between the pro-inflammatory Th17 cell
population and immunosuppressive Treg cells is critical
for immune homeostasis (Wu et al., 2016); imbalances
are associated with various inflammatory and autoimmune
diseases, including MS, which is linked to a shift towards
increased Th17 cell levels (Venkatesha et al., 2015). Here, we
report that miR-384 over-expression leads to an imbalance
in Th17/Treg ratios, resulting in exacerbation of EAE with
severe demyelination, through the promotion of Th17 cell
differentiation by targeting SOCS3. This miR-384-associated
Th17/Treg imbalance represents a potential therapeutic target
for MS and a novel indicator of disease risk (Yu et al.,
2015).
The SOCS family consists of intracellular proteins that
are key physiological regulators of the immune system.
SOCS3 is an important member of the SOCS family and
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can negatively regulate the IL-6-JAK-STAT3 pathway, which
is indispensable for Th17 cell differentiation (Qu et al.,
2012; Liu X. et al., 2015). SOCS3-deficient T cells show
hyperactivation of STAT3 and significantly increased secretion
of IL-17, induced by IL-6 (Chen et al., 2006). Therefore,
miR-384 promotes the differentiation of Th17 cells, which
disturbs the Th17/Treg ratio, through targeting of SOCS3.
However, there do not appear to be any direct effects of
miR-384 on Treg cell development. This may be because
SOCS3 is involved in specific inhibition of STAT3, but not
STAT5, signaling. The STAT5 pathway is activated by TGF-β
to induce Foxp3 expression and Treg cell development (Basu
et al., 2015). The mutually inhibitory roles of Th17 and Treg
cells may be responsible for the slight decrease in Treg cells
when Th17 cell generation is promoted by miR-384 in EAE
mice and their slight increase when miR-384 is knocked down
(Figure 3C).
miR-384, the role of which has previously been poorly
understood, has recently been the focus of research attention.
miR-384 has suppressive effects on tumor cell proliferation
through the direct inhibition of IRS1 expression (Lai et al.,
2016), and contributes to aberrant Runx expression in prostate
tumors (Farina et al., 2016). In addition, several studies have
demonstrated a relationship between miR-384 and the CNS.
Gu et al. (2015) used next-generation sequencing to profile
miRNA transcriptomes, and found that miR-384 is required
for enduring synaptic and spinal plasticity by regulation of the
expression of RSK3. Another study demonstrated that miR-384
is a promising candidate as a biomarker of spinal cord injury,
because of a significant increase in miR-384 in the serum,
which correlates with injury severity (Hachisuka et al., 2014). In
addition, miR-384 is elevated in the hippocampus during neural
cell death and is, therefore, considered to have potentially novel
roles in neurotoxicity (Ogata et al., 2015) and the development of
Parkinson’s disease (Jiang et al., 2016) and Alzheimer’s disease
(Liu et al., 2014). In this study, we discovered another novel
function of miR-384, namely a critical involvement in the
development of the Th17/Treg imbalance and demyelination in
the CNS during the pathogenesis of EAE through targeting of
SOCS3.
The fact that an increase of the Th17/Treg ratio in MS
patients vs. healthy controls (Jamshidian et al., 2013) implies
recovering the balance between Th17 and Treg cells may be
an important target in the context of inflammation. All trans
retinoic acid (ATRA), as a RORγt antagonist, has been proved
to ameliorate EAE severity via the following mechanisms:
(1) inhibition of Th17 cell differentiation by binding to the
RARα sequence to downregulate RORγt expression and then
increase Foxp3+ T cells (Hall et al., 2011; Egan et al., 2016);
and (2) Th17 cell dysfunction due to the decrease in IL-23
and IL-6 receptor expression accompanied by the promotion
of TGF-β signaling through the Smad3 pathway in Treg
cells (Klemann et al., 2009; Abdolahi et al., 2015). Recent
transcriptional network analysis has identified a core set of
transcription factors, such as STAT3, which are crucial for
the differentiation of Th17 cell by inducing RORγt expression
and DNA binding (Ciofani et al., 2012). In addition, distinct
miRNAs, the post-transcriptional modulators of RNA stability,
have been reported to regulate the Th17 cell differentiation
by modulating the amount of transcripts that encode crucial
positive regulators of Th17 cell development (Korn and Kallies,
2017). It is encouraging that the miR-based therapy has
been in clinical trials (Gebert et al., 2014), offering a novel
therapeutic approach if miRNAs can be effectively applied
in vivo.
In conclusion, we found that the expression of miR-384
is greatly increased during the pathogenesis of EAE, and
that its over-expression in vivo leads to severe EAE, due
to aggravated demyelination caused by the promotion
of Th17 cell generation. In addition, this microRNA
promotes Th17 cell differentiation through targeting
SOCS3. These results facilitate better understanding of
the pathogenesis of EAE and imply that miR-384 may be
an effective biomarker or potential therapeutic target in
MS.
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